Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with McBride on European Licence

8 Feb 2011 07:00

RNS Number : 8317A
Byotrol PLC
08 February 2011
 



 

 

8 February 2011

 

 

Byotrol plc

Heads of agreement with McBride on European licence

and Consumer Products update

 

Byotrol plc ('Byotrol'), the developer of anti microbial hygiene technologies, is pleased to announce that it has extended the scope of its agreement between Byotrol Consumer Products Ltd (BCP) and Robert McBride Ltd (McBride) through a heads of agreement to jointly develop and sell residual action liquid disinfectants in the European market. It is now expected that the first product will be launched in the first half of 2011. Financial details of the agreement are restricted due to the confidential nature of the negotiations.

 

It is also the intention of BCP and McBride to enter into full licence agreements, with UK product launches expected in Q2 and Q3 of this calendar year of Byotrol-based household care products. 

 

At the announcement of Byotrol's Interim results, a number of consumer products negotiations were disclosed. An update on those negotiations follows:

 

Products that were licensed under the Tommee Tippee baby brand in the UK and Ireland, announced in December, are already being sold in a number of leading retailers in the UK and will be available nationally over the coming weeks. The Byotrol-based products sold under the Tommee Tippee Closer to Nature range include hand sanitizer gels, trigger spray surface cleaner and sterilizing fluid.

 

BCP has signed a licence agreement with PZ Cussons plc for Byotrol-based liquid all purpose cleaners to be sold in Nigeria, under the market-leading Morning Fresh brand. Products are already being sold in multiple retail outlets in Nigeria and there is an intention to extend the product sales into further countries in Sub-Saharan Africa.

 

BCP is pleased to report continued and constructive product development discussions with the Fortune 150 company previously announced.

 

Commenting on the developments at BCP, Gary Millar, Chief Executive at Byotrol, said:

 

"The consumer products sector is a fast moving product area, as shown by the significant developments that we are seeing at BCP across a wide range of product areas and territories. This momentum is encouraging, and a vital contributor to our ability to negotiate with both existing and new partners for additional opportunities.

 

"At the announcement of our Interim results we outlined our refocused strategy and our core target markets. It is therefore pleasing to be able to demonstrate the successful outcome of our efforts through these agreements with highly respected consumer products organisations.

 

"Our strategy has always been to achieve scale and market reach through partnering with specialist distributors and partners with proven sector expertise and experience. These contracts endorse that approach."

 

 

Enquiries:

 

Byotrol plc 0161 277 9518

Gary Millar, Chief Executive

Richard Bell, Finance Director

 

Arbuthnot Securities 020 7012 2000

Nominated Adviser and broker

Antonio Bossi / Henry Willcocks

 

Winningtons 020 3176 4722

Tom Cooper / Paul Vann 0797 122 1972

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRSSWFAWFFSEEE
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.